Table 3.
Laboratory variables, % variation of the analyzed population (signed rank).
| Variable | Patients Undergoing High-Dose Vitamin C Treatment (n = 104) |
Patients Not Undergoing High-Dose Vitamin C Treatment (n = 42) |
p |
|---|---|---|---|
| Hemoglobin (gr/dL) | −5.2 (−10.9–1.8) | −3.6 (−14.9–4.4) | 0.5064 |
| White cells (cell/uL) | 24.4 (−6.8–75.9) | 1.1 (−23.7–52.5) | 0.0656 |
| Neutrophils (cell/uL) | 16.2 (−22.9–81.5) | −18.6 (−40.6–31.8) | 0.0126 |
| Linfocytes (cell/uL) | 43.2 (2.8–99.6) | 38.6 (−7.4–125) | 0.9161 |
| Platelets (cell/µL) | 12.1 (−19.4–48.6) | 0 (−15.8–27.7) | 0.1735 |
| PCR (mg/dL) | −83.9 (−95.0–−10.1) | −82.5 (−95.0–−19.2) | 0.7957 |
| Procalcitonin (PCT) (of/L) | 0 (−51.4–0) | 0 (−63.1–0) | 0.5827 |
| eGFR (mL/min/m2) | 7.7 (0.4–24.2) | 4.5 (−7.7–31.0) | 0.3599 |
| D-Dimer (ng/mL) | −2.6 (−50.3–40.7) | −14.1 (−58.6–2.1) | 0.2604 |
| Hematocrit (%) | −4.1 (−9.6–2.4) | −1.3 (−10.1–4.9) | 0.3407 |
| Monocytes (cell/µL) | 21.6 (−16.0–71.9) | 18.7 (−15.0–103.7) | 0.9335 |
| Sodium (mmol/L) | 0 (−2.1–2.2) | 1.4 (−0.7–2.9) | 0.1853 |
| Glycemia (mg/dL) | −11.2 (−29.9–24.5) | −10.2 (−28.8–16.5) | 0.9702 |
Data reported as medians (Q1–Q3).